Vastra Gotaland Region
Clinical trials sponsored by Vastra Gotaland Region, explained in plain language.
-
Heart attack patients: which blood thinner is safer?
Disease control CompletedThis study looked at over 17,000 people who had a heart attack to compare two blood thinners: prasugrel and ticagrelor. Hospitals switched from ticagrelor to prasugrel in a stepwise way to see which drug better prevents death, another heart attack, or stroke. The goal is to find …
Phase: PHASE4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to keep early lung cancer from returning
Disease control CompletedThis study tested whether giving the drug durvalumab after precise radiation therapy (SBRT) helps people with early-stage lung cancer stay cancer-free longer. About 106 patients with stage I non-small cell lung cancer who could not have surgery or chose not to were randomly assig…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental combo targets Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs—177Lu-DOTA-TATE (a radioactive therapy) and olaparib (a PARP inhibitor)—in 18 people with certain cancers like neuroendocrine tumors, thymoma, or mesothelioma that have a specific marker (somatostatin receptor). The goal wa…
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could one drug replace two after a heart attack stent?
Disease control CompletedThis study looked at whether using only ticagrelor (a blood thinner) after heart attack stenting is safe, instead of the usual two-drug combination. It included 200 adults who had a stent placed during a heart attack. The main goal was to check for serious heart problems or stent…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Own immune cells delivered to liver to fight melanoma
Disease control CompletedThis early-phase trial tested whether it is safe and feasible to give patients their own immune cells (called tumor infiltrating lymphocytes, or TIL) directly into the liver artery. Eight adults with melanoma that had spread to the liver received the TIL infusion along with chemo…
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a classroom program keep teen depression at bay?
Prevention CompletedThis study tests a program called 'Thoughts and Health' designed to prevent depression in adolescents. The program is delivered in 12 sessions in a school setting. Researchers will see if it helps students' mental health and their ability to finish junior high with passing grades…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Video-Game workouts boost lung Patients' fitness at home
Symptom relief CompletedThis study tested whether a home-based exercise program using an exergaming (video-game exercise) system, supervised remotely by a physiotherapist, could improve physical fitness and quality of life in people with COPD. 92 participants were randomly assigned to either the exergam…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Thin vs. thick stents: which is better value for heart patients?
Knowledge-focused CompletedThis study looked at two different heart stents (tiny mesh tubes used to open blocked arteries) to see which one works better in routine hospital care. Over 1,000 patients who needed a stent took part. The goal was to compare costs, procedure time, and how many extra devices were…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
13-Year study reveals how chronic back pain evolves in women
Knowledge-focused CompletedThis study follows 87 women who had chronic low back pain 13 years ago to see how their pain, daily activities, and ability to work have changed. Researchers are looking for patterns that might predict who will improve or worsen over time. The goal is to better understand the lon…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Cystic fibrosis and COVID: are patients naturally protected?
Knowledge-focused CompletedThis study followed 113 people with cystic fibrosis (CF) over two years to see how many developed antibodies against COVID-19, either from infection or vaccination. Researchers collected blood samples and health data to understand if CF patients have a lower infection rate and ho…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New knee measurement device put to the test in ACL patients
Knowledge-focused CompletedThis study looked at whether a device called the GNRB arthrometer can reliably measure knee looseness (laxity) in people with an ACL tear, both before and after reconstructive surgery. Seventeen adults with a first-time ACL injury were tested by two examiners using the GNRB and a…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Massive study digs into what predicts joint replacement in osteoarthritis patients
Knowledge-focused CompletedThis large observational study followed over 288,000 people with hip or knee osteoarthritis who received core treatment (education, exercise, and weight loss advice). The goal was to identify factors like socioeconomic status and other health conditions that predict long-term out…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC